Pharmagreen Biotech, Inc.’s (OTCPINK: PHBI) interview with Mr. Peter Wojcik, CEO

0
118

See the full episode at: https://newtothestreet.com/new-to-the-street-241-october-3rd-2021-hapbee-technologies-tonix-pharmaceuticals-first-wave-biopharma-globex-data-strikeforce-technologies-kylin-network-sekur

New to The Street TV interviews Mr. Peter Wojcik, Chief Executive Officer, Pharmagreen Biotech, Inc. (OTCPINK:PHBI), who provides a comprehensive overview to TV Host, Jane King. Throughout the interview, Peter talks about the pending US SEC Reg A+ financing and explains the use-of-proceeds to grow the Company’s starter cannabis plantlets through its proprietary tissue culture process. With total proceeds of cash and stock combination totaling approximately $2.4 Million, PHBI should have adequate capital to complete the acquisition of the California-based Cannabis Licensed Company and to construct state-of-the-art greenhouse. Mr. Wojcik further explains that, upon the closing of the acquisition, the Company intends to apply to the State of California for a cannabis nursery license to enable it to develop its “Tissue Culture Starter Plantlet” production facility. He advises viewers who might be interested in participating in the Reg A+ funding to read about it once available on the Company’s website landing page at www.pharmagreen.ca. He thanks the viewers and the Company’s shareholders and invited them to view future TV interviews on the New to The Street’s syndicated airings and read social media and website updates.

To make sure you never miss a video from New to the Street, click here to subscribe: https://www.youtube.com/channel/UCceRKKS0QUfXlKUPBoxdTHQ

Follow New to the Street on Twitter: https://twitter.com/NewToTheStreet
Follow New to the Street on Facebook: https://www.facebook.com/newtothestreet/
Follow New to the Street on Instagram: https://www.instagram.com/newtothestreettv/
Follow New to the Street on Rumble: https://rumble.com/user/newtothestreet
About New to the Street: https://newtothestreet.com/

Subscribe to our Mailing List: https://mailchi.mp/ccd21b3e3fab/join-our-mailing-list